Recent Finacing
Recent Raise
Palleon Pharmaceuticals develops glycan-targeted therapeutics for cancer and inflammatory diseases using EAGLE enzymatic sialoglycan degradation, HYDRA tumor glycan profiling, and Siglec-targeted drug discovery.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Palleon Pharmaceuticals.
